Every I.V. site presents the potential for infection, dislodgement, skin damage, and other complications. These complications can potentially cause patient discomfort and pain, extended hospital stays, additional therapy, and surgical intervention—even increased patient mortality.
3M Science has allowed for unique innovations that give you what you need to protect every I.V. catheter—from insertion to removal.
Our broad portfolio makes it easy for you to choose and use the right products: from hand hygiene, skin preps and barrier films,transparent dressings, and disinfecting caps.
We can help you deliver compassionate care with evidence-based products to protect patient and clinician safety, help prevent the risks of costly complications, and improve patient satisfaction.
The Infusion Nurses Society (INS) has recently updated its Standards of Practices to reflect current infusion and vascular access practices. Lisa Gorski, chairman of both the 2011 and 2016 INS Standards of Practice Committee, presents a two-part program that updates Vascular Access clinicians and those responsible for the care and maintenance of Vascular Access Devices. The 2016 Infusion Therapy Standards of Practice reflect updated practice criteria that have been evaluated based on strength of evidence.
Catheter -reelated bloodstream infections (CRBSIs) are one of the most serius and costly health care-acquired infections (HAIs), leading to increased costs associated with extended hospital stays, illness and death. The estimated average cost for treating a single CRBSI is $29,5001 per episode in Australia and between $20,000 to $54,000 2 in New Zealand.
Choose 3M™ Tegaderm™ CHG Dressings,an I.V. Securement Dressing with an integrated antimicrobial Chlorhexidine Gluconate (CHG) gel pad to help reduce the risk of contamination from flora on the surface of the skin.3
Use 3M™ Curos™ Disinfecting Port Protectorsto disinfect and protect needleless connectors and to help reduce the risk of contaminants from entering the catheter post-insertion.
Each Curos disinfecting product contains 70% isopropyl alcohol (IPA). The IPA bathes the surface of the I.V. access port and disinfects it in 3 minutes. The effectiveness of Curos disinfecting port protectors was tested in vitro against Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, Pseudomonas aeruginosa, Candida glabrata, and Candida albicans and was found to have >4 log reduction.
Learn about all the benefits of Curos disinfecting port protectors here.
Providing exceptional I.V. site care is a tough job. You’re expected to ensure I.V. sites are stable and secure, manage the risks of healthcare-acquired infections, provide a positive patient experience, and keep an eye on the bottom line.
The Centers for Disease Control and Prevention (CDC) Guidelines for the Prevention of Intravascular Catheter-Related Infections, 2011 and The Infusion Nurses Society (INS) Nursing Standards of Practice, 2011, recommend the use of a catheter stabilization device for all I.V. catheters.4,5
3M™ Tegaderm™ I.V. Advanced Securement Dressings include a deep notch, stabilization border, and dual adhesive technology to provide the comfort and protection your patients deserve. These dressings meet the CDC and INS definitions as a catheter securement or stabilization device.4,5
The thin film backing of 3M™ Tegaderm™ Transparent Film Dressingsis occlusive to liquids, bacteria and viruses,* but allows water vapor, oxygen and carbon dioxide to be exchanged. The sterile film includes a hypoallergenic adhesive, that is not made with natural rubber latex, that enables long wear time and full site visibility to minimize unnecessary dressing changes.
* In vitro testing shows that the transparent film provides a viral barrier from viruses 27 nm in diameter or larger while the dressing remains intact without leakage.
Maintenance of healthy skin around a vascular access device is critical to reducing the risk of infection, maintaining a securement dressing or device, and patient comfort. Although Medical Adhesive-Related Skin Injuries (MARSI) continue across care specialties, they do not need to be an inevitable part of the patient experience. Skin integrity can be maintained even when repeated dressing changes are required. Preparation of the skin and selection of proper adhesives are the first steps to help minimize the risks of MARSI.6
3M™ Cavilon™ No Sting Barrier Film forms a protective barrier between the skin and the adhesive of the securement dressing, device or medical tape to help reduce the risk of Medical Adhesive-Related Skin Injury (MARSI). When an adhesive product is removed from the skin, Cavilon No Sting Barrier Film is removed instead of skin cells.
3M™ Medical Tapes provide a variety of backings and adhesives that allow you to select the most appropriate adhesive product based on its intended purpose. To help reduce the risk of cross contamination among patients, 3M offers many of its tapes in single-patient use rolls.7
1. Magill SS, Edwards JR, Bamberg W, et al. Multistate Point-Prevalence Survey of Health Care–Associated Infections. N Engl J Med 2014;370:1198-208.
2. Marschall J, Mermel LA, Fakih M, et al. Strategies to Prevent Central Line-Associated Bloodstream Infections in Acute Care Hospitals: 2014 Update Infect Control Hosp Epidemiol 2014;35(7):753-771
3. Mermel, LA, McCormick, RD, Springman, SR, Maki, DG. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: A prospective study utilizing molecular sub-typing. American Journal of Medicine. (1991) 91; 197S-205S.
4. Centers for Disease Control and Prevention. Guidelines for the Prevention of Intravascular Catheter-related Infections. Healthcare Infection Control (Appendix 1). Clin Infect Dis, 2011; 52(9):e162.
5. Infusion Therapy Standards of Practice, 2016.
6. McNichol L, Lund C, Rosen T, Gray M. Medical Adhesives and Patient Safety: State of the Science. Journal Wound Ostomy Continence Nursing. 2013; 40(4): 365-380.
7. Infection Control Today Vol 17, No. 1, Single-Patient Rolls of Medical Tapes Reduce Cross-Contamination Risk (January 2013).